Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 641
Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Login 
     

    Article Cited by others

GUEST COMMENTARY

Visceral leishmaniasis

Sundar Shyam

Year : 2015| Volume: 5| Issue : 2 | Page no: 83-85

   This article has been cited by
 
1 Leishmaniasis Beyond East Africa
Caitlin M. Jones,Susan C. Welburn
Frontiers in Veterinary Science. 2021; 8
[Pubmed]  [Google Scholar] [DOI]
2 PF-429242, a Subtilisin Inhibitor, Is Effective in vitro Against Leishmania infantum
Patrícia de Almeida Machado,Pollyanna Stephanie Gomes,Victor Midlej,Elaine Soares Coimbra,Herbert Leonel de Matos Guedes
Frontiers in Microbiology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
3 Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis
Shabi Parvez,Ganesh Yadagiri,Mallikarjuna Rao Gedda,Aakriti Singh,Om Prakash Singh,Anurag Verma,Shyam Sundar,Shyam Lal Mudavath
Scientific Reports. 2020; 10(1)
[Pubmed]  [Google Scholar] [DOI]
4 Evaluating the immunomodulatory responses of Ld ODC-derived MHC Class-II restricted peptides against VL
RajKishor Pandey,Manas Ranjan Dikhit,Avinash Kumar,Budheswar Dehury,Krishna Pandey,Roshan Kamal Topno,Pradeep Das,Sanjiva Bimal
Parasite Immunology. 2020; 42(4)
[Pubmed]  [Google Scholar] [DOI]
5 Visceral Leishmaniasis Treatment Outcome and Associated Factors in Northern Ethiopia
Kidu Gidey,Desalegn Belay,Berhane Yohannes Hailu,Tesfaye Dessale Kassa,Yirga Legesse Niriayo
BioMed Research International. 2019; 2019: 1
[Pubmed]  [Google Scholar] [DOI]
6 Modulation of TLR4 Sialylation Mediated by a Sialidase Neu1 and Impairment of Its Signaling in Leishmania donovani Infected Macrophages
Joyshree Karmakar,Saptarshi Roy,Chitra Mandal
Frontiers in Immunology. 2019; 10
[Pubmed]  [Google Scholar] [DOI]
7 Epidemiological situations and control strategies of vector-borne diseases in Nepal during 1998–2016
Shanker Bahadur Shrestha,Uttam Raj Pyakurel,Mukti Khanal,Murari Upadhyay,Kesara Na-Bangchang,Phunuch Muhamad
Journal of Health Research. 2019; 33(6): 478
[Pubmed]  [Google Scholar] [DOI]
8 Assessment of quality of life using WHOQOL-BREF in patients with visceral leishmaniasis
Rajendra Babu Veeri,Ashok Kumar Gupta,Biplab Pal,Niyamat Ali Siddiqui,Devi Priya,Pradeep Das,Krishna Pandey
Health and Quality of Life Outcomes. 2019; 17(1)
[Pubmed]  [Google Scholar] [DOI]
9 Decentralized control of human visceral leishmaniasis in endemic urban areas of Brazil: a literature review
Sonia S. Menon,Rodolfo Rossi,Leon Nshimyumukiza,Kate Zinszer
Tropical Medicine and Health. 2016; 44(1)
[Pubmed]  [Google Scholar] [DOI]
10 Ruthenium-Clotrimazole complex has significant efficacy in the murine model of cutaneous leishmaniasis
Eva Iniguez,Armando Varela-Ramirez,Alberto Martínez,Caresse L. Torres,Roberto A. Sánchez-Delgado,Rosa A. Maldonado
Acta Tropica. 2016; 164: 402
[Pubmed]  [Google Scholar] [DOI]
11 Coccinia grandis (L.) Voigt Leaf Extract Exhibits Antileishmanial Effect Through Pro-inflammatory Response: An In Vitro Study
Asmita Pramanik,Dibyendu Paik,Kshudiram Naskar,Tapati Chakraborti
Current Microbiology. 2016;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article